Skip to content
← Back to this collection

PUBLICATIONS · 28578601

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2017 Aug 10
First author
Robson M

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2017 Oct 26;377(17):1700. doi: 10.1056/NEJMx170012.
    note
    Source null
    related pmid
    28792849
    relationship
    Erratum in
  2. citation
    N Engl J Med. ;377(18):1792. doi: 10.1056/NEJMc1711644.
    note
    Source null
    related pmid
    29094857
    relationship
    Comment in

Authors and identifiers

  1. name
    Robson M
    type
    Author
  2. name
    Im SA
    type
    Author
  3. name
    Senkus E
    type
    Author
  4. name
    Xu B
    type
    Author
  5. name
    Domchek SM
    type
    Author
  6. name
    Masuda N
    type
    Author
  7. name
    Delaloge S
    type
    Author
  8. name
    Li W
    type
    Author
  9. name
    Tung N
    type
    Author
  10. name
    Armstrong A
    type
    Author
  11. name
    Wu W
    type
    Author
  12. name
    Goessl C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Robson M
    type
    Author
  2. name
    Im SA
    type
    Author
  3. name
    Senkus E
    type
    Author
  4. name
    Xu B
    type
    Author
  5. name
    Domchek SM
    type
    Author
  6. name
    Masuda N
    type
    Author
  7. name
    Delaloge S
    type
    Author
  8. name
    Li W
    type
    Author
  9. name
    Tung N
    type
    Author
  10. name
    Armstrong A
    type
    Author
  11. name
    Wu W
    type
    Author
  12. name
    Goessl C
    type
    Author
bibliography ids
  1. nci-bib-37a748f50ab16e30438784a9
book metadata
content sha256
d6642f1d11551632f7d2fafc7ddba84a500141a3650198144d62f80f679a19f3
document type
citation
dois
  1. 10.1056/NEJMoa1706450
electronic publication date
display
2017 Jun 4
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28578601
immutable id
pubmed:28578601@d6642f1d11551632f7d2fafc7ddba84a500141a3650198144d62f80f679a19f3
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
6
name
The New England journal of medicine
nlm unique id
0255562
pages
523-533
volume
377
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2017 Oct 26;377(17):1700. doi: 10.1056/NEJMx170012.
    note
    Source null
    related pmid
    28792849
    relationship
    Erratum in
  2. citation
    N Engl J Med. ;377(18):1792. doi: 10.1056/NEJMc1711644.
    note
    Source null
    related pmid
    29094857
    relationship
    Comment in
outcomes validated
false
pmid
28578601
provenance
batch id
1c173f0e18be0c6d461b
provider
NCBI PubMed ESummary
record sha256
fd804711761ab80fbc3f668a8bf4cda99bb222047a7ef1f188737c6368d0a2eb
response sha256
27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
retrieved at
2026-09-09T23:47:25.975513+00:00
publication date
display
2017 Aug 10
precision
day
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28578601/
title
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.

Preserved source evidence · Not medical advice